Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Coursaget

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Clinical and Vaccine Immunology : CVI|November 9, 2007
Detection of human papillomavirus type 31-neutralizing antibodies from naturally infected patients by an assay based on intracellular assembly of luciferase-expressing pseudovirionsMaxime J J Fleury, Antoine Touzé, Silvia de Sanjosé, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|June 17, 2010
Investigation of the prevalence of antibodies against neurotropic polyomaviruses BK, JC and SV40 in sera from patients affected by multiple sclerosisTatiana Ribeiro, Maxime J Fleury, Enrico Granieri, et al.
Clinical and Vaccine Immunology : CVI|January 11, 2013
Age-specific seroprevalences of merkel cell polyomavirus, human polyomaviruses 6, 7, and 9, and trichodysplasia spinulosa-associated polyomavirusJérôme T J Nicol, Rémy Robinot, Audrey Carpentier, et al.
European Journal of Immunology|September 18, 2014
Natural killer and dendritic cells collaborate in the immune response induced by the vaccine against uterine cervical cancerInge Langers, Virginie Renoux, Anca Reschner, et al.
Journal of Clinical Microbiology|November 1, 2013
Seroprevalence of human Malawi polyomavirusJérôme T J Nicol, Valérie Leblond, Françoise Arnold, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|October 3, 2013
Hepatitis E virus seroprevalence and risk factors for individuals in working contact with animalsHélène Chaussade, Emma Rigaud, Aurore Allix, et al.
Vaccine|October 7, 2008
Induction of antibody response against hepatitis E virus (HEV) with recombinant human papillomavirus pseudoviruses expressing truncated HEV capsid proteins in miceVirginie M G Renoux, Maxime J J Fleury, Latifa Bousarghin, et al.
Journal of Clinical Microbiology|March 7, 2002
Detection of neutralizing antibodies against human papillomaviruses (HPV) by inhibition of gene transfer mediated by HPV pseudovirionsLatifa Bousarghin, Alba-Lucia Combita-Rojas, Antoine Touzé, et al.
Journal of Medical Virology|October 29, 2005
Mutations on the FG surface loop of human papillomavirus type 16 major capsid protein affect recognition by both type-specific neutralizing antibodies and cross-reactive antibodiesGuillaume S Carpentier, Maxime J J Fleury, Antoine Touzé, et al.
The Lancet. Infectious Diseases|May 27, 2009
Clinician's guide to human papillomavirus immunology: knowns and unknownsMark H Einstein, John T Schiller, Raphael P Viscidi, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Clinical and Vaccine Immunology : CVI|November 9, 2007
Detection of human papillomavirus type 31-neutralizing antibodies from naturally infected patients by an assay based on intracellular assembly of luciferase-expressing pseudovirionsMaxime J J Fleury, Antoine Touzé, Silvia de Sanjosé, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|June 17, 2010
Investigation of the prevalence of antibodies against neurotropic polyomaviruses BK, JC and SV40 in sera from patients affected by multiple sclerosisTatiana Ribeiro, Maxime J Fleury, Enrico Granieri, et al.
Clinical and Vaccine Immunology : CVI|January 11, 2013
Age-specific seroprevalences of merkel cell polyomavirus, human polyomaviruses 6, 7, and 9, and trichodysplasia spinulosa-associated polyomavirusJérôme T J Nicol, Rémy Robinot, Audrey Carpentier, et al.
European Journal of Immunology|September 18, 2014
Natural killer and dendritic cells collaborate in the immune response induced by the vaccine against uterine cervical cancerInge Langers, Virginie Renoux, Anca Reschner, et al.
Journal of Clinical Microbiology|November 1, 2013
Seroprevalence of human Malawi polyomavirusJérôme T J Nicol, Valérie Leblond, Françoise Arnold, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|October 3, 2013
Hepatitis E virus seroprevalence and risk factors for individuals in working contact with animalsHélène Chaussade, Emma Rigaud, Aurore Allix, et al.
Vaccine|October 7, 2008
Induction of antibody response against hepatitis E virus (HEV) with recombinant human papillomavirus pseudoviruses expressing truncated HEV capsid proteins in miceVirginie M G Renoux, Maxime J J Fleury, Latifa Bousarghin, et al.
Journal of Clinical Microbiology|March 7, 2002
Detection of neutralizing antibodies against human papillomaviruses (HPV) by inhibition of gene transfer mediated by HPV pseudovirionsLatifa Bousarghin, Alba-Lucia Combita-Rojas, Antoine Touzé, et al.
Journal of Medical Virology|October 29, 2005
Mutations on the FG surface loop of human papillomavirus type 16 major capsid protein affect recognition by both type-specific neutralizing antibodies and cross-reactive antibodiesGuillaume S Carpentier, Maxime J J Fleury, Antoine Touzé, et al.
The Lancet. Infectious Diseases|May 27, 2009
Clinician's guide to human papillomavirus immunology: knowns and unknownsMark H Einstein, John T Schiller, Raphael P Viscidi, et al.
Pageof 6